Effects of fluticasone/salmeterol (Advair) in outpatients with chronic obstructive pulmonary disease (COPD) acute exacerbation
Phase of Trial: Phase III
Latest Information Update: 16 Jun 2011
At a glance
- Drugs Prednisone; Salmeterol/fluticasone propionate
- Indications Chronic obstructive pulmonary disease
- Focus Biomarker; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 16 Jun 2011 Actual initiation date (Nov 2007) added as reported by ClinicalTrials.gov.
- 16 Jun 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.